[1] |
YIN Ya, PAN Yuan, ZHOU Hongwei, SHEN Wei.
Application progress of BNP and NT-proBNP in neonates
[J]. Laboratory Medicine, 2023, 38(6): 518-523.
|
[2] |
LI Li, SUN Haiyan, LI Yuanrui, DOU Min, TANG Wen, JIANG Limin, SHEN Lisong.
Changes and clinical roles of perioperative NT-proBNP and PCT in children with congenital heart disease
[J]. Laboratory Medicine, 2023, 38(6): 524-531.
|
[3] |
LIU Yanan, XIA Min, HU Shaohua, ZHENG Yue, ZHANG Hong.
Roles of lymphocyte subsets,inflammatory factors and NT-proBNP in diagnosis of Kawasaki disease
[J]. Laboratory Medicine, 2023, 38(6): 532-537.
|
[4] |
CHEN Bin, LU Weiwei, XU Zhongyu.
Roles of serum NT-proBNP,CRP and MMP-9 in children with Kawasaki disease
[J]. Laboratory Medicine, 2020, 35(3): 243-246.
|
[5] |
YANG Yan, ZHANG Fujun, SHEN Songkun, WANG Houzhao.
NT-proBNP,cTnI,Hcy,DD and hs-CRP for the diagnosis of coronary heart disease by ROC curves
[J]. Laboratory Medicine, 2018, 33(1): 15-19.
|
[6] |
WU Shuzhi,DENG Sheng,QIN Weiguo,CHEN Jian,YI Bin..
The clinical significance on the combined determination of NT-proBNP, H-FABP and cTnI in elder patients with severe heart failure
[J]. , 2014, 29(4): 312-318.
|
[7] |
LIU Chengeng, XIA Ming, WANG Jinling, LI Lei, WANG Peichang.
The significance of serum anti-carbonic anhydrase Ⅱ and Ⅲ auto-antibody determination in patients with congestive heart failure
[J]. , 2014, 29(2): 97-99.
|
[8] |
YUAN Jinke.
The role of serum copeptin in the diagnosis and treatment of dilated cardiomyopathy patients with heart failure
[J]. , 2013, 28(7): 563-566.
|
[9] |
WU Shuzhi.
The significance of serum NT-proBNP for the future risk evaluation of major adverse cardiac events in elderly patients with stable coronary artery disease
[J]. , 2013, 28(7): 567-572.
|
[10] |
ZHU Lanyun;MI Xiuhua;YANG Lianli;XU Laishun;CHE Xiaoqiong.
Early changes of plasma N-terminal pro-B-type natriuretic peptide original in cardiac injury
[J]. , 2012, 27(5): 358-360.
|
[11] |
LU Yide;YANG Fan;LU Qiuya;SHI Xinming;FAN Qishi.
Investigation of the serum N-terminal pro-B-type natriuretic peptide reference intervals in apparently healthy individuals
[J]. , 2009, 24(12): 874-877.
|